Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

SIMPLE SUMMARY: More than 50% of gastric cancer are at least locally advanced at presentation. For such patients, a multimodal approach rather than mere surgical resection leads to better long-term prognosis. Neoadjuvant chemoradiotherapy is one of the common treatment strategies for local advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Jen-Hao, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Huang, Ching-Wen, Chang, Tsung-Kun, Su, Wei-Chih, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221037/
https://www.ncbi.nlm.nih.gov/pubmed/35740693
http://dx.doi.org/10.3390/cancers14123026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221037/
https://www.ncbi.nlm.nih.gov/pubmed/35740693
http://dx.doi.org/10.3390/cancers14123026

Ejemplares similares